Back

Antiplatelet therapy after coronary bypass grafting: which regimen and for whom?

European Heart Journal - Cardiovascular Pharmacotherapy

19 October 2020
Organised by: Logo
Read full article
ESC Journals

Contributors

Andrea Rubboli
Andrea Rubboli

Author

Santa Maria delle Croci Hospital Ravenna , Italy

Sabine Vecchio
Sabine Vecchio

Author

You may be interested in
thumbnail
Congress Presentation
Ticagrelor-based dual antiplatelet therapy versus aspirin monotherapy after CABG: a systematic review and meta-analysis of randomized controlled trials
30 August 2026
thumbnail
Congress Presentation
Antithrombotic prescription in secondary cardiovascular prevention: are we following the guidelines?
4 April 2025
thumbnail
Congress Presentation
Perioperative risk and benefit of antiplatelet therapy in patients undergoing non-cardiac surgery within 1 year after percutaneous coronary intervention with second-generation drug-eluting stents.
27 August 2022
thumbnail
Congress Presentation
In patients undergoing coronary artery bypass grafting, hemodynamic impairment is linked to the intensity of the post-surgical inflammatory burst
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources